Drug Hunter
Home > Merck IDO1 inhibitor
heme-displacing IDO1 inhibitor
human predicted QD dose of 26 mg
from 260k MS-based screen and SBDD
ACS Med. Chem. Lett. Mar. 10, 2020
Merck, Boston, MA
Merck IDO1 inhibitor (Merck heme-displacing oral IDO1 inhibitor)
Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.
Request a trial to access insights powering the pros in our industry.
March 2020
Molecules of the Month
01
January
02
February
03
March
04
April
05
May
06
June
07
July
08
August
09
September
10
October
11
November
12
December
MOTY Nominees
Molecule of the Year